| |
|
| |
ThromboGenics is a leading biopharmaceutical company focused on the discovery and development of novel therapeutics
for diseases related to... more » |
|
|
|
|
 |
|
| |
ThromboGenics has developed a strong pipeline of products for the treatment of a broad range of conditions related to the vasculature, including visual disorders, ... more » |
|
|
|
|
|
|
| |
September 1, 2010
Microplasmin meets primary endpoint in second phase III trial in VMA, confirms positive findings of first trial.. more »
Microplasmine behaalt primair eindpunt in tweede fase III studie en bevestigt de positieve resultaten van de eerste studie... meer »
|
|
|
|
All rights reserved © ThromboGenics 2006